Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack L Arbiser

Showing results (21-30 of 214) with videos related to

Pageof 22
Sort By:
Blood|January 31, 2009
The hunting of the SnrkJack L Arbiser, Levi Fried
Pigment Cell & Melanoma Research|April 4, 2008
The reactive oxygen-driven tumor: relevance to melanomaLevi Fried, Jack L Arbiser
Molecular Therapy. Nucleic Acids|September 8, 2023
MAVS is a double-edged swordChristina Huang, Jack L Arbiser
Journal of the American Academy of Dermatology|February 5, 2005
Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositisUma Nadiminti, Jack L Arbiser
The British Journal of Dermatology|November 30, 2023
Skp2: A new therapeutic target of psoriasisYing Wang, Jack L Arbiser
Journal of Drugs in Dermatology : JDD|May 6, 2025
Successful Treatment of Sacral Pressure Injury With ACU-D1Christina Huang, Jack L Arbiser
The Journal of Investigative Dermatology|March 27, 2018
Targeting the Plasticity of PsoriasisJack L Arbiser, Justin Elsey
Cancers|July 14, 2023
Targeting the Vulnerabilities of Oncogene ActivationChristina Huang, Jack L Arbiser
Antioxidants & Redox Signaling|February 11, 2009
Honokiol, a multifunctional antiangiogenic and antitumor agentLevi E Fried, Jack L Arbiser
The Journal of Investigative Dermatology|February 24, 2016
Seborrheic Keratoses: The Rodney Dangerfield of Skin lesions, and Why They Should Get Our RespectJack L Arbiser, Michael Y Bonner
Pageof 22

Showing results (21-30 of 214) with videos related to

Sort By:
Pageof 22
Blood|January 31, 2009
The hunting of the SnrkJack L Arbiser, Levi Fried
Pigment Cell & Melanoma Research|April 4, 2008
The reactive oxygen-driven tumor: relevance to melanomaLevi Fried, Jack L Arbiser
Molecular Therapy. Nucleic Acids|September 8, 2023
MAVS is a double-edged swordChristina Huang, Jack L Arbiser
Journal of the American Academy of Dermatology|February 5, 2005
Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositisUma Nadiminti, Jack L Arbiser
The British Journal of Dermatology|November 30, 2023
Skp2: A new therapeutic target of psoriasisYing Wang, Jack L Arbiser
Journal of Drugs in Dermatology : JDD|May 6, 2025
Successful Treatment of Sacral Pressure Injury With ACU-D1Christina Huang, Jack L Arbiser
The Journal of Investigative Dermatology|March 27, 2018
Targeting the Plasticity of PsoriasisJack L Arbiser, Justin Elsey
Cancers|July 14, 2023
Targeting the Vulnerabilities of Oncogene ActivationChristina Huang, Jack L Arbiser
Antioxidants & Redox Signaling|February 11, 2009
Honokiol, a multifunctional antiangiogenic and antitumor agentLevi E Fried, Jack L Arbiser
The Journal of Investigative Dermatology|February 24, 2016
Seborrheic Keratoses: The Rodney Dangerfield of Skin lesions, and Why They Should Get Our RespectJack L Arbiser, Michael Y Bonner
Pageof 22